Close
Close
Actinium Receives Positive from EMA for AML
271 views
1.0
1.0 from 2 votes

Executive Chairman of Actinium Pharmaceuticals discusses his company's positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathway for Actinium, an Acute Myeloid Leukemia (AML) drug.

Learn more about:

Access Programs

by Scott Harwood
3 views 1 day ago
by Abidemi Uruejoma
9 views 1 day ago
by Scott Harwood
9 views 4 days ago
by Scott Harwood
8 views 4 days ago
by Abidemi Uruejoma
37 views 1 week ago
by Scott Harwood
26 views 2 weeks ago
by Scott Harwood
26 views 2 weeks ago
by Abidemi Uruejoma
84 views 1 month ago
1.0
1.0 from 2 votes
Free Newsletter
Find a Clinical Trial
Related Videos
News Articles